ID   LB1610-MEL
AC   CVCL_E915
DR   cancercelllines; CVCL_E915
DR   Wikidata; Q54902036
RX   PubMed=28765120;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=28765120).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=28765120).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 9
//
RX   PubMed=28765120; DOI=10.1158/2326-6066.CIR-16-0400;
RA   Hennequart M., Pilotte L., Cane S., Hoffmann D., Stroobant V.,
RA   De Plaen E., van den Eynde B.J.;
RT   "Constitutive IDO1 expression in human tumors is driven by
RT   cyclooxygenase-2 and mediates intrinsic immune resistance.";
RL   Cancer Immunol. Res. 5:695-709(2017).
//